Please assess the completion status of the following clinical trial:

Trial Title: Use of a Medical Food in Adults Undergoing Surgery

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Participant is scheduled to have non-melanoma skin cancer on either the head, leg, trunk and arm removed with final wound size of 1.0 to \< 5.0 cm in diameter or with 1.0 \< 5.0 cm long axis if not circular that will be healed by secondary intent~* Participant has an acceptable state of health and nutrition~* Participant agrees not to begin taking any new medications, dietary supplements, or alternative therapies during the study period~* Participant is interested in participating in the study, willing to comply with the study protocol, and willing to consume two servings of drink mix per day according to the protocol~* Participant has voluntarily signed and dated an informed consent form (ICF), approved by an Independent Ethics Committee/Institutional Review Board (IEC/IRB) and provided Health Insurance Portability and Accountability (HIPAA) authorization prior to any study participation~Exclusion Criteria:~* Participant has a disease or condition that could interfere with the assessment of safety and efficacy of the study treatment and compliance of the participant with study visits/procedures~* Participant has type 1 diabetes mellitus or uncontrolled type 2 diabetes mellitus~* Participant has known immunosuppression~* Participant has platelet or coagulation disorders~* Therapy with another investigational agent within 30 days of Visit 1 that has not been approved~* Systemic infection at the time of enrollment in the study~* Currently receiving or have received recombinant human platelet-derived growth factor or similar therapies, or other bioengineered tissue therapy within the previous 4 weeks~* Participant has an allergy or intolerance to any ingredient in the study product~* Participant is taking nutritional supplement(s)/capsules/formulas for wound healing and is unwilling to discontinue therapy for the duration of the study~* Participation in another clinical study

- Gender: ALL
- Minimum Age: 60 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Experimental Product (Type: EXPERIMENTAL): Drink mix powder

Based on this trial design, predict the completion outcome and termination type (if applicable).